A
Aura Biosciences, Inc.
AURA · NASDAQ · Healthcare · 795M
Closing price
$6.54
+0.54% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.9×
Enterprise value / EBITDAEV/EBITDA
-3.4×
Free cash flow yieldFCF yield
-21.6%
Return on equityROE
-77.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.